Market Cap 9.44B
Revenue (ttm) 1.61B
Net Income (ttm) 282.33M
EPS (ttm) N/A
PE Ratio 64.25
Forward PE 45.20
Profit Margin 17.53%
Debt to Equity Ratio 0.00
Volume 104,579,700
Avg Vol 74,218,625
Day's Range N/A - N/A
Shares Out 518.12M
Stochastic %K 10%
Beta 1.02
Analysts Sell
Price Target $14.53

Company Profile

UiPath, Inc. provides an automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. It offers the UiPath platform, an integrated enterprise software platform that enables AI agents, robots, people, and models to work together in coordinated workflows. The company's UiPath platform includes the UiPath Maestro process orchestration and process intelligence; UiPath agent bui...

Industry: Software - Infrastructure
Sector: Technology
Phone: 844 432 0455
Address:
One Vanderbilt Avenue, 60th Floor, New York, United States
TakeChances321go
TakeChances321go Sep. 5 at 8:30 PM
$PATH Total price manipulation after earnings. Stay the course, long term hold for $$$ At least the analysts are turning the corner: BMO: $13$18 TD Cowen: $13$16 Barclays: $14$17 Mizuho: $12$14 BofA: $13$15 Wells Fargo: $13$15 Canaccord: $15$17 RBC: $15$17 and Needham $22
0 · Reply
Dukeit
Dukeit Sep. 5 at 7:42 PM
$PATH Good earnings beat and it drops. It’s just a shakeout. Sell plebes, stay poor. I remember Palantir doing something similar, drove me crazy and created doubt and a loss of confidence in my decision making. It’s a mindfuck.
2 · Reply
AIIAAIIA_88
AIIAAIIA_88 Sep. 5 at 6:22 PM
$PATH Thanks for the correction. Added. I know that this will reclaim the old highs and then some soon enough. 2027 will be a fantastic year for it. JMO
0 · Reply
longshot45
longshot45 Sep. 5 at 6:12 PM
$PATH What do we think? Another day of massive shorting Tuesday to fill the gap to 14 and finish scaring those quaking? Then the slow climb back up…
1 · Reply
alaric_wong89
alaric_wong89 Sep. 5 at 6:00 PM
$PATH every bounce getting sold into is the thing worth watching today.
0 · Reply
BULLMANURETradah
BULLMANURETradah Sep. 5 at 4:37 PM
$PATH lucky I got out before earning. With small profit. Almost fomo back in on earning fake pop
1 · Reply
HeyKat
HeyKat Sep. 5 at 2:33 PM
$PATH this guy was posting non stop FUD before last earnings. And then the stock went up 80%
2 · Reply
Panicsellerr
Panicsellerr Sep. 5 at 12:25 PM
$PATH clearly goes back to 12$ eventually and no more 18$ up untill next earnings…
2 · Reply
LegUpTrade
LegUpTrade Sep. 5 at 9:16 AM
$PATH https://www.instagram.com/reel/DcrPC-URn_T/?igsi=eGlwenhxYW94YTJt
0 · Reply
DizPlinTrading
DizPlinTrading Sep. 5 at 8:47 AM
$PATH This new journey is only beginning for UiPath. Know what you own 🤝
1 · Reply
Latest News on PATH
UiPath price target raised to $17 from $12 at Truist

2026-09-04T13:10:09.000Z - 1 day ago

UiPath price target raised to $17 from $12 at Truist


UiPath price target raised to $16 from $12 at DA Davidson

2026-09-04T12:50:19.000Z - 1 day ago

UiPath price target raised to $16 from $12 at DA Davidson


UiPath price target raised to $16 from $13 at TD Cowen

2026-09-04T12:25:11.000Z - 1 day ago

UiPath price target raised to $16 from $13 at TD Cowen


UiPath price target raised to $17 from $15 at RBC Capital

2026-09-04T11:55:09.000Z - 1 day ago

UiPath price target raised to $17 from $15 at RBC Capital


UiPath price target raised to $18 from $13 at BMO Capital

2026-09-04T11:45:26.000Z - 1 day ago

UiPath price target raised to $18 from $13 at BMO Capital


UiPath price target raised to $15 from $13 at BofA

2026-09-04T11:30:11.000Z - 1 day ago

UiPath price target raised to $15 from $13 at BofA


UiPath price target raised to $14 from $12 at Mizuho

2026-09-04T11:05:33.000Z - 1 day ago

UiPath price target raised to $14 from $12 at Mizuho


UiPath price target raised to $17 from $14 at Barclays

2026-09-04T11:00:33.000Z - 1 day ago

UiPath price target raised to $17 from $14 at Barclays


UiPath price target raised to $15 from $13 at Wells Fargo

2026-09-04T10:25:34.000Z - 1 day ago

UiPath price target raised to $15 from $13 at Wells Fargo


UiPath downgraded to Hold from Buy at Canaccord

2026-09-04T09:35:15.000Z - 1 day ago

UiPath downgraded to Hold from Buy at Canaccord


UiPath Earnings Call Transcript: Q2 2027

Sep 3, 2026, 5:00 PM EDT - 1 day ago

UiPath Earnings Call Transcript: Q2 2027


UiPath Earnings release: Q2 2027

Sep 3, 2026, 5:00 PM EDT - 1 day ago

UiPath Earnings release: Q2 2027


UiPath Slides: Q2 2027

Sep 3, 2026, 5:00 PM EDT - 1 day ago

UiPath Slides: Q2 2027


UiPath names Ramani CFO, Gupta COO

2026-09-03T20:21:25.000Z - 2 days ago

UiPath names Ramani CFO, Gupta COO


UiPath reports Q2 adjusted EPS 15c, consensus 15c

2026-09-03T20:15:38.000Z - 2 days ago

UiPath reports Q2 adjusted EPS 15c, consensus 15c


UiPath sees Q3 revenue $440M-$445M, consensus $441.17M

2026-09-03T20:15:24.000Z - 2 days ago

UiPath sees Q3 revenue $440M-$445M, consensus $441.17M


UiPath Reports Second Quarter Fiscal 2027 Financial Results

Sep 3, 2026, 4:10 PM EDT - 2 days ago

UiPath Reports Second Quarter Fiscal 2027 Financial Results


UiPath to Participate in the Citi 2026 Global TMT Conference

Sep 1, 2026, 4:10 PM EDT - 4 days ago

UiPath to Participate in the Citi 2026 Global TMT Conference


UiPath Announces Upcoming Investor Day

Aug 25, 2026, 8:30 AM EDT - 11 days ago

UiPath Announces Upcoming Investor Day


UiPath Transcript: AGM 2026

Jun 25, 2026, 11:00 AM EDT - 2 months ago

UiPath Transcript: AGM 2026


UiPath Earnings Call Transcript: Q1 2027

May 28, 2026, 5:00 PM EDT - 3 months ago

UiPath Earnings Call Transcript: Q1 2027


UiPath Earnings release: Q1 2027

May 28, 2026, 5:00 PM EDT - 3 months ago

UiPath Earnings release: Q1 2027


UiPath Slides: Q1 2027

May 28, 2026, 5:00 PM EDT - 3 months ago

UiPath Slides: Q1 2027


UiPath Quarterly report: Q1 2027

May 28, 2026, 5:00 PM EDT - 3 months ago

UiPath Quarterly report: Q1 2027


UiPath Reports First Quarter Fiscal 2027 Financial Results

May 28, 2026, 4:10 PM EDT - 3 months ago

UiPath Reports First Quarter Fiscal 2027 Financial Results


UiPath Proxy statement: Proxy filing

May 22, 2026, 8:00 AM EDT - 3 months ago

UiPath Proxy statement: Proxy filing


UiPath Proxy statement: Proxy filing

May 12, 2026, 8:00 AM EDT - 3 months ago

UiPath Proxy statement: Proxy filing


UiPath Proxy statement: Proxy filing

May 12, 2026, 8:00 AM EDT - 3 months ago

UiPath Proxy statement: Proxy filing


UiPath Transcript: Status update

Apr 6, 2026, 11:30 AM EDT - 5 months ago

UiPath Transcript: Status update


UiPath stock: why sell-off makes sense despite Q4 beat and buyback

Mar 12, 2026, 12:48 PM EDT - 5 months ago

UiPath stock: why sell-off makes sense despite Q4 beat and buyback


UiPath Earnings Call Transcript: Q4 2026

Mar 11, 2026, 5:00 PM EDT - 5 months ago

UiPath Earnings Call Transcript: Q4 2026


UiPath Annual report: Q4 2026

Mar 11, 2026, 5:00 PM EDT - 5 months ago

UiPath Annual report: Q4 2026


UiPath Earnings release: Q4 2026

Mar 11, 2026, 5:00 PM EDT - 5 months ago

UiPath Earnings release: Q4 2026


UiPath Slides: Q4 2026

Mar 11, 2026, 5:00 PM EDT - 5 months ago

UiPath Slides: Q4 2026


UiPath Annual report: Q4 2026

Mar 11, 2026, 5:00 PM EDT - 5 months ago

UiPath Annual report: Q4 2026


UiPath Profit, Revenue Rise as AI Adoption Spreads

Mar 11, 2026, 4:57 PM EDT - 5 months ago

UiPath Profit, Revenue Rise as AI Adoption Spreads


TakeChances321go
TakeChances321go Sep. 5 at 8:30 PM
$PATH Total price manipulation after earnings. Stay the course, long term hold for $$$ At least the analysts are turning the corner: BMO: $13$18 TD Cowen: $13$16 Barclays: $14$17 Mizuho: $12$14 BofA: $13$15 Wells Fargo: $13$15 Canaccord: $15$17 RBC: $15$17 and Needham $22
0 · Reply
Dukeit
Dukeit Sep. 5 at 7:42 PM
$PATH Good earnings beat and it drops. It’s just a shakeout. Sell plebes, stay poor. I remember Palantir doing something similar, drove me crazy and created doubt and a loss of confidence in my decision making. It’s a mindfuck.
2 · Reply
AIIAAIIA_88
AIIAAIIA_88 Sep. 5 at 6:22 PM
$PATH Thanks for the correction. Added. I know that this will reclaim the old highs and then some soon enough. 2027 will be a fantastic year for it. JMO
0 · Reply
longshot45
longshot45 Sep. 5 at 6:12 PM
$PATH What do we think? Another day of massive shorting Tuesday to fill the gap to 14 and finish scaring those quaking? Then the slow climb back up…
1 · Reply
alaric_wong89
alaric_wong89 Sep. 5 at 6:00 PM
$PATH every bounce getting sold into is the thing worth watching today.
0 · Reply
BULLMANURETradah
BULLMANURETradah Sep. 5 at 4:37 PM
$PATH lucky I got out before earning. With small profit. Almost fomo back in on earning fake pop
1 · Reply
HeyKat
HeyKat Sep. 5 at 2:33 PM
$PATH this guy was posting non stop FUD before last earnings. And then the stock went up 80%
2 · Reply
Panicsellerr
Panicsellerr Sep. 5 at 12:25 PM
$PATH clearly goes back to 12$ eventually and no more 18$ up untill next earnings…
2 · Reply
LegUpTrade
LegUpTrade Sep. 5 at 9:16 AM
$PATH https://www.instagram.com/reel/DcrPC-URn_T/?igsi=eGlwenhxYW94YTJt
0 · Reply
DizPlinTrading
DizPlinTrading Sep. 5 at 8:47 AM
$PATH This new journey is only beginning for UiPath. Know what you own 🤝
1 · Reply
NilleGris
NilleGris Sep. 5 at 8:15 AM
$PATH Overreacted stock reaction yesterday, ended up picking up a few more shares. The future is looking bright, my friends. Now it's time for champagne at the top of the Eiffel Tower 🥂
1 · Reply
Walakulu2000
Walakulu2000 Sep. 5 at 8:07 AM
$PATH game over.
3 · Reply
Nardi86
Nardi86 Sep. 5 at 7:48 AM
$PATH iykyk
0 · Reply
Dazza933
Dazza933 Sep. 5 at 7:25 AM
$PATH where will we be end of September? Why?
2 · Reply
honestbuck
honestbuck Sep. 5 at 7:01 AM
Look at all the bots posting FUD in here. 🧛‍♂️Friday's data shows they are shorting harder than ever. Large scale and foolish bears are hopelessly trapped on the wrong side of this trade and praying you capitulate by attempting to manipulate you. Why? Good question thank you for asking. Because $PATH consistently grows revenue on an annual basis. Has beat and raised each earnings. Is GAAP profitable. Zero debt. Cash, cash equivalents, and marketable securities were $1.405 billion as of July 31, 2026. Analysts just upgraded price targets and IMO the best developments and partnerships are in the pipeline to be reported at NEXT earnings. Based on facts and not opinions and scare tactics, does this quarterly revenue growth compared against short interest make sense to you? Going to reply to myself with one additional image showing short sale volume including 9/04/2026.👀
1 · Reply
ThePharmaguy
ThePharmaguy Sep. 5 at 6:15 AM
$PATH junk
0 · Reply
nopennys
nopennys Sep. 5 at 5:30 AM
$PATH oh no what did the CEO say bla bla bla but no Bullish guidance.
0 · Reply
SydneyLyons429
SydneyLyons429 Sep. 5 at 5:21 AM
$PATH still can't prove durable growth reacceleration, and every bounce keeps getting sold into. Risk/reward looks skewed to the downside until they show real numbers, not just AI buzzword slides. Feels like a show-me story that keeps disappointing. Not chasing this one.
0 · Reply
SandraPedersen118
SandraPedersen118 Sep. 5 at 5:02 AM
$PATH growth story keeps getting harder to believe every quarter. Automation hype only takes a stock so far without real acceleration. Competition is heating up and the "growth potential" narrative feels tired at this point. Not seeing the catalyst bulls keep waiting for.
0 · Reply
aaviar
aaviar Sep. 5 at 3:52 AM
$PATH we’ll bounce back up post investor day
0 · Reply
CoffeeRocks
CoffeeRocks Sep. 5 at 2:44 AM
$AKAN $ACB $HELP $PATH $TLRY https://www.marijuanamoment.net/trump-releases-more-federal-marijuana-prisoners-as-dea-considers-rescheduling-cannabis/
2 · Reply
TimeTaEat
TimeTaEat Sep. 5 at 1:57 AM
$PATH 👀
0 · Reply